Patents Assigned to Rosetta Genomics Lts
  • Publication number: 20120232124
    Abstract: Described herein are compositions and methods for prognosis and treatment of prostate cancer patients. Specifically the invention relates to microRNA molecules associated with the prognosis of prostate cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: July 20, 2010
    Publication date: September 13, 2012
    Applicant: Rosetta Genomics Lts
    Inventors: Ayelet Chajut, Shai Rosenwald